Moleculin Biotech receives Nasdaq notice over $1 minimum bid
Nasdaq Staff determined Moleculin Biotech failed to meet the $1.00 minimum bid price requirement for 30 consecutive business days under Listing Rule 5550(a)(2).
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.